Compare RLAY & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RLAY | MATH |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 49.9M |
| IPO Year | 2020 | 2016 |
| Metric | RLAY | MATH |
|---|---|---|
| Price | $17.29 | $1.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $28.25 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 29.1K |
| Earning Date | 11-04-2026 | 08-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,355,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $63.45 | N/A |
| P/E Ratio | ★ N/A | $3.10 |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $6.25 | $0.73 |
| 52 Week High | $21.27 | $3.19 |
| Indicator | RLAY | MATH |
|---|---|---|
| Relative Strength Index (RSI) | 44.31 | 52.88 |
| Support Level | $17.33 | $0.93 |
| Resistance Level | $17.40 | $1.13 |
| Average True Range (ATR) | 1.24 | 0.09 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 19.14 | 60.26 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Metalpha Technology Holding Ltd mainly operates in the trading of proprietary digital assets and derivative contracts in Hong Kong. The Company's primary business operations center on digital asset services, offered through its subsidiaries. The Company generates income mainly from executing cryptocurrency-related transactions, including providing derivative solutions to over-the-counter (OTC) clients, issuing derivative products to OTC clients, and engaging in proprietary trading activities. The Company provides crypto derivative solutions and liquidity to its clients, facilitated through its principal trading activities, enabling seamless trading of crypto derivative solutions. The Company generates revenue from Hong Kong.